Roche and Fluidigm to Co-Market 454's Sequencers, Fluidigm's Multiplexed PCR Arrays
October 19, 2010
Roche and Fluidigm to Co-Market 454's Sequencers, Fluidigm's Multiplexed PCR Arrays
The companies said they will offer a "robust and streamlined workflow" that minimizes the number of manual steps required for targeted sequencing applications.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Fluidigm and Roche 454 Co-Promoting Amplicon Sample Prep, Next-Gen Sequencing Platforms
October 21, 2010 / PCR Insider - 454 GS Junior Drives 1 Percent Growth in Roche's Sequencing, Array Business in Q1
April 19, 2011 / In Sequence - NuGen, Roche's 454 Team to Provide Sample Prep for Low-Abundance RNA Sequencing
April 7, 2011 / PCR Insider - Roche's Sequencing Business Grows 12 Percent YTD as Applied Science Sales Shrink in Q3
October 19, 2010 / In Sequence - For 454 Technology, Roche Bets on Specific Apps, Taking Share from Sanger
August 10, 2010 / In Sequence